Company announcements Home » Investors » News » Company announcements » Dealing in securities by directors and prescribed officers: vesting of shares and settlement by on market sales and equity settlement 2022 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 2008 2007 2006 2005 2004 2003 2002 Dealing in securities by directors and prescribed officers: vesting of shares and settlement by on market sales and equity settlementOctober 27, 2022 Johannesburg, Thursday, 27 October 2022. In compliance with paragraphs 3.63 to 3.74 of the JSE Listings Requirements, the following dealings in securities by directors and prescribed officers of Harmony in relation to the vesting and settlement of deferred share awards made pursuant to the provisions of the Harmony Deferred Share Plan 2018 are disclosed: 1. Name of director:PW Steenkamp (Chief Executive Officer) Nature of transaction:Vesting of deferred share awards and settlement by on-market sale of shares, in terms of the Harmony Deferred Share Plan 2018 Vesting Date:18 September 2022 Class of securities:Ordinary shares Number of ordinary shares vested:192 557 Number of ordinary shares locked up towards minimum shareholding requirement:39 493 Number of vested shares sold on market:153 064 Date of conclusion of bulk on-market sale of shares:21 October 2022 On-market sale price per share:Volume weighted average price of R47.41 per share (with a low of R46.66 per share and a high of R48.25 per share) Total value of shares sold on market prior to deduction of tax liability:R7 256 764 Number of shares retained in own name:0 Total value of shares retained in own name:R0 Nature and extent of prescribed officer’s interest:Direct beneficial 2. Name of director: BP Lekubo (Financial Director) Nature of transaction:Vesting of deferred share awards and settlement by on-market sale of shares, in terms of the Harmony Deferred Share Plan 2018 Vesting Date:18 September 2022 Class of securities:Ordinary shares Number of ordinary shares vested:44 704 Number of ordinary shares locked up towards minimum shareholding requirement:19 004 Number of vested shares sold on market:25 700 Date of conclusion of bulk on-market sale of shares:21 October 2022 On-market sale price per share:Volume weighted average price of R47.41 per share (with a low of R46.66 per share and a high of R48.25 per share) Total value of shares sold on market prior to deduction of tax liability:R1 218 437 Number of shares retained in own name:0 Total value of shares retained in own name:R0 Nature and extent of prescribed officer’s interest:Direct beneficial 3. Name of director:HE Mashego (Executive Director) Nature of transaction:Vesting of deferred share awards and settlement by on-market sale of shares, in terms of the Harmony Deferred Share Plan 2018 Vesting Date:18 September 2022 Class of securities:Ordinary shares Number of ordinary shares vested:36 202 Number of ordinary shares locked up towards minimum shareholding requirement:18 100 Number of vested shares sold on market:18 102 Date of conclusion of bulk on-market sale of shares:21 October 2022 On-market sale price per share:Volume weighted average price of R47.41 per share (with a low of R46.66 per share and a high of R48.25 per share) Total value of shares sold on market prior to deduction of tax liability:R858 216 Number of shares retained in own name:0 Total value of shares retained in own name:R0 Nature and extent of prescribed officer’s interest:Direct beneficial 4. Name of prescribed officer:B Nel Nature of transaction:Vesting of deferred share awards and settlement by on-market sale of shares, in terms of the Harmony Deferred Share Plan 2018 Vesting Date:18 September 2022 Class of securities:Ordinary shares Number of ordinary shares vested:36 840 Number of ordinary shares locked up towards minimum shareholding requirement:18 419 Number of vested shares sold on market:18 421 Date of conclusion of bulk on-market sale of shares:21 October 2022 On-market sale price per share:Volume weighted average price of R47.41 per share (with a low of R46.66 per share and a high of R48.25 per share) Total value of shares sold on market prior to deduction of tax liability:R873 340 Number of shares retained in own name:0 Total value of shares retained in own name:R0 Nature and extent of prescribed officer’s interest:Direct beneficial 5. Name of prescribed officer:M van der Walt Nature of transaction:Vesting of deferred share awards and settlement by on-market sale of shares, in terms of the Harmony Deferred Share Plan 2018 Vesting Date:18 September 2022 Class of securities:Ordinary shares Number of ordinary shares vested:34 689 Number of ordinary shares locked up towards minimum shareholding requirement:9 870 Number of vested shares sold on market to cover tax:11 540 Date of conclusion of bulk on-market sale of shares:21 October 2022 On-market sale price per share:Volume weighted average price of R47.41 per share (with a low of R46.66 per share and a high of R48.25 per share) Total value of shares sold on market to cover tax:R547 111 Number of shares retained in own name:13 279 Total value of shares retained in own name:R629 557 Nature and extent of prescribed officer’s interest:Direct beneficial 6. Name of prescribed officer:J van Heerden Nature of transaction:Vesting of deferred share awards and settlement by on-market sale of shares, in terms of the Harmony Deferred Share Plan 2018 Vesting Date:18 September 2022 Class of securities:Ordinary shares Number of ordinary shares vested:47 734 Number of ordinary shares locked up towards minimum shareholding requirement:23 866 Number of vested shares sold on market:23 868 Date of conclusion of bulk on-market sale of shares:21 October 2022 On-market sale price per share:Volume weighted average price of R47.41 per share (with a low of R46.66 per share and a high of R48.25 per share) Total value of shares sold on market prior to deduction of tax liability:R1 131 582 Number of shares retained in own name:0 Total value of shares retained in own name:R0 Nature and extent of prescribed officer’s interest:Direct beneficial 7. Name of prescribed officer:A Buthelezi Nature of transaction:Vesting of deferred share awards and settlement by on-market sale of shares, in terms of the Harmony Deferred Share Plan 2018 Vesting Date:18 September 2022 Class of securities:Ordinary shares Number of ordinary shares vested:31 675 Number of vested shares sold on market:31 675 Date of conclusion of bulk on-market sale of shares:21 October 2022 On-market sale price per share:Volume weighted average price of R47.41 per share (with a low of R46.66 per share and a high of R48.25 per share) Total value of shares sold on market prior to deduction of tax liability:R1 501 712 Number of shares retained in own name:0 Total value of shares retained in own name:R0 Nature and extent of prescribed officer’s interest:Direct beneficial 8. Name of prescribed officer:M Naidoo-Vermaak Nature of transaction:Vesting of deferred share awards and settlement by on-market sale of shares, in terms of the Harmony Deferred Share Plan 2018 Vesting Date:18 September 2022 Class of securities:Ordinary shares Number of ordinary shares vested:34 901 Number of vested shares sold on market:34 901 Date of conclusion of bulk on-market sale of shares:21 October 2022 On-market sale price per share:Volume weighted average price of R47.41 per share (with a low of R46.66 per share and a high of R48.25 per share) Total value of shares sold on market prior to deduction of tax liability:R1 654 656 Number of shares retained in own name:0 Total value of shares retained in own name:R0 Nature and extent of prescribed officer’s interest:Direct beneficial Prior clearance was obtained in respect of the above dealings in securities in compliance with paragraph 3.66 of the JSE Listings Requirements. Ends. For more details contact: Jared CoetzerHead of Investor Relations+27 (0) 82 746 4120 Johannesburg, South Africa27 October 2022 Sponsor:J.P. Morgan Equities South Africa Proprietary Limited